2-p-(2-[(2-hydroxy-3-phenoxypropyl)amino]ethoxy)phenoxyacetamide | 107332-86-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 2-p-(2-[(2-hydroxy-3-phenoxypropyl)amino]ethoxy)phenoxyacetamide
• 英文别名: Acetamide, 2-[4-[[2-(2-hydroxy-3-phenoxypropyl)A；2-[4-[2-[(2-hydroxy-3-phenoxypropyl)amino]ethoxy]phenoxy]acetamide
• CAS: 107332-86-5
• 化学式: C₁₉H₂₄N₂O₅
• 分子量: 360.41
• InChiKey: CYHLHUZPQKUJRA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  26
• 可旋转键数：
  12
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  103
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  2-p-(2-[(2-hydroxy-3-phenoxypropyl)amino]ethoxy)phenoxyacetamide 以 盐酸 为溶剂， 生成 <4-<2-<(2-hydroxy-3-phenoxypropyl)amino>ethoxy>phenoxy>acetic acid hydrochloride
  参考文献：
  名称：

  Phenyl ethers

  摘要：

  本发明涉及一系列新型苯氧基乙酸醚（及其药学上可接受的盐），其化学式为I式，其中R.sup.1为H或F，R.sup.2和R.sup.3为H或（1-3C）烷基，Z为CH.sub.2 OH或一个--CO.R.sup.4基团，其中R.sup.4为OH，NH.sub.2或（1-6C）烷氧基。本发明还包括用于治疗肥胖和相关疾病的制药组合物，并提供了制造新型醚的方法。

  公开号：

  US04772631A1
• 作为产物：
  描述：

  methyl <4-<2-<(2-hydroxy-3-phenoxypropyl)amino>ethoxy>phenoxy>acetate 在 氨 作用下， 以 甲醇 、 乙醇 为溶剂， 生成 2-p-(2-[(2-hydroxy-3-phenoxypropyl)amino]ethoxy)phenoxyacetamide
  参考文献：
  名称：

  Selective .beta.3-adrenergic agonists of brown adipose tissue and thermogenesis. 1. [4-[2-[(2-Hydroxy-3-phenoxypropyl)amino]ethoxy]phenoxy]acetates

  摘要：

  The ester methyl [4-[2-[(2-hydroxy-3-phenoxypropyl)amino]ethoxy]phenoxy]acetate (8) has been identified as the most interesting member of a series of selective beta-3-adrenergic agonists of brown adipose tissue and thermogenesis in the rat. In vivo it acts mainly via the related acid 10. Potency was generally markedly reduced by placing substituents on the phenyl ring of the phenoxypropanolamine unit of 8; only the 2-fluoro analogue 16 had comparable potency to 8. Other structure-activity relationships are discussed. Further testing of 8 (ICI 198157) has shown that in the rat it stimulates the beta-3-adrenergic receptor in brown adipose tissue at doses lower than those at which it affects beta-1 and beta-2 adrenergic receptors in other tissues. It increases metabolic rate, as judged by an increase in oxygen consumption, and in the genetically obese Zucker rat it causes a reduced rate of weight gain. This class of compound may be useful in the treatment of obesity in man.

  DOI：

  10.1021/jm00088a009

文献信息

• 2-Hydroxy-3-phenoxypropyl amines
  申请人：IMPERIAL CHEMICAL INDUSTRIES PLC

  公开号：EP0210849B1

  公开（公告）日：1990-08-29
• US4772631A
  申请人：——

  公开号：US4772631A

  公开（公告）日：1988-09-20
• Selective .beta.3-adrenergic agonists of brown adipose tissue and thermogenesis. 1. [4-[2-[(2-Hydroxy-3-phenoxypropyl)amino]ethoxy]phenoxy]acetates
  作者：Ralph Howe、Balbir S. Rao、Brian R. Holloway、Donald Stribling

  DOI：10.1021/jm00088a009

  日期：1992.5

  The ester methyl [4-[2-[(2-hydroxy-3-phenoxypropyl)amino]ethoxy]phenoxy]acetate (8) has been identified as the most interesting member of a series of selective beta-3-adrenergic agonists of brown adipose tissue and thermogenesis in the rat. In vivo it acts mainly via the related acid 10. Potency was generally markedly reduced by placing substituents on the phenyl ring of the phenoxypropanolamine unit of 8; only the 2-fluoro analogue 16 had comparable potency to 8. Other structure-activity relationships are discussed. Further testing of 8 (ICI 198157) has shown that in the rat it stimulates the beta-3-adrenergic receptor in brown adipose tissue at doses lower than those at which it affects beta-1 and beta-2 adrenergic receptors in other tissues. It increases metabolic rate, as judged by an increase in oxygen consumption, and in the genetically obese Zucker rat it causes a reduced rate of weight gain. This class of compound may be useful in the treatment of obesity in man.
• Phenyl ethers
  申请人：Imperial Chemical Industries PlC

  公开号：US04772631A1

  公开（公告）日：1988-09-20

  The invention concerns a series of novel phenoxyacetic acid ethers (and pharmaceutically acceptable salts thereof) of the formula I in which R.sup.1 is H or F, R.sup.2 and R.sup.3 are H or (1-3C)alkyl, Z is CH.sub.2 OH or a group --CO.R.sup.4 in which R.sup.4 is OH, NH.sub.2 or (1-6C)alkoxy. The invention also includes pharmaceutical compositions for use in treating obesity and related conditions and provides processes for the manufacture of the novel ethers.

  本发明涉及一系列新型苯氧基乙酸醚（及其药学上可接受的盐），其化学式为I式，其中R.sup.1为H或F，R.sup.2和R.sup.3为H或（1-3C）烷基，Z为CH.sub.2 OH或一个--CO.R.sup.4基团，其中R.sup.4为OH，NH.sub.2或（1-6C）烷氧基。本发明还包括用于治疗肥胖和相关疾病的制药组合物，并提供了制造新型醚的方法。